Frontiers Association of Lipoprotein(a)-Associated Mortality and

Por um escritor misterioso
Last updated 25 julho 2024
Frontiers  Association of Lipoprotein(a)-Associated Mortality and
Frontiers  Association of Lipoprotein(a)-Associated Mortality and
Lipoprotein(a) Reduction in Persons with Cardiovascular Disease
Frontiers  Association of Lipoprotein(a)-Associated Mortality and
Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study - The Lancet Diabetes & Endocrinology
Frontiers  Association of Lipoprotein(a)-Associated Mortality and
Lipoprotein(a) and Risk of Coronary, Cerebrovascular, and Peripheral Artery Disease
Frontiers  Association of Lipoprotein(a)-Associated Mortality and
Subgroup analyses of Kaplan–Meier (KM) survival curves according to
Frontiers  Association of Lipoprotein(a)-Associated Mortality and
Frontiers HDL Composition, Heart Failure, and Its Comorbidities
Frontiers  Association of Lipoprotein(a)-Associated Mortality and
Clinical Feature: The ABCs of Lipoprotein(a)
Frontiers  Association of Lipoprotein(a)-Associated Mortality and
The relationship of low-density lipoprotein cholesterol and all-cause or cardiovascular mortality in patients with type 2 diabetes: a retrospective study [PeerJ]
Frontiers  Association of Lipoprotein(a)-Associated Mortality and
Lipoprotein(a) and Cardiovascular Disease in Chinese Population: A Beijing Heart Society Expert Scientific Statement
Frontiers  Association of Lipoprotein(a)-Associated Mortality and
Lipoprotein(a): An independent, genetic, and causal factor for cardiovascular disease and acute myocardial infarction - ScienceDirect

© 2014-2024 empresaytrabajo.coop. All rights reserved.